Beliefs about cervical cancer and human papillomavirus (HPV) and acceptability of HPV vaccination among Chinese women in Hong Kong

This publication has 9 references indexed in Scilit:

• Overview of Cervical Cancer in the Developing World
  International Journal of Gynecology & Obstetrics, 2006
• Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
  The Lancet, 2006
• HPV vaccines
  Best Practice & Research Clinical Obstetrics & Gynaecology, 2006
• Future acceptance of adolescent human papillomavirus vaccination: A survey of parental attitudes
  Vaccine, 2006
• Parental acceptance of the human papillomavirus vaccine
  Journal of Adolescent Health, 2005
• Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
  The Lancet Oncology, 2005
• Against which human papillomavirus types shall we vaccinate and screen? the international perspective
  International Journal of Cancer, 2004
• Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK
  British Journal of Cancer, 2003
• Evaluation of Human Papillomavirus Testing in Primary Screening for Cervical Abnormalities
  JAMA, 2002